NHLBI Funding & Resource Opportunities

national heart, lung and blood institute logo image

Office of Translational Alliances and Coordination

Is my project of interest to NIH?

This is a question we get asked regularly!  As a general rule - if you are developing a biomedical technology the answer will be yes, BUT, you can verify this for yourself! There is a searchable database of science award information from 17 federal funding agencies, including NIH, FDA, CDC, and NSF. The database (Federal RePORTER) is updated annually and includes information for ~900,000 projects.
 
NIH has also developed the NIH RePORTER database which includes a “Matchmaker” tab.  If you enter your specific aims or project summary you will find similar projects that have been funded by the NIH, which institutes funded those projects, which study sections reviewed them, and potential collaborators or SBIR/STTR-funded companies in your subject or geographic area to ask for advice.


Looking to learn more about the new Human Subject and Clinical Trial Information form?

NIH is updating application forms to FORMS-E for due dates of Jan 25, 2018 and beyond. FORMS-E includes a brand new form. Check it out using the resources below. 


For more information, please read the full Notice: NOT-OD-17-062


Oct 27 deadline - SBIR Program Contract Solicitation

PHS 2018-1

Extended deadline: October 27, 2017, 5:00PM ET

Submit proposals through eCPS website

The National Heart, Lung, and Blood Institute invites small business concerns to submit research proposals under the Small Business Innovation Research (SBIR) Contract Solicitation. Firms with the capability to conduct research and development (R&D) in any of the health-related topic areas below and to commercialize the results of that R&D, are encouraged to participate. 

  •  Devices for Transcatheter Surgery
  • Tapered Guidewires for Transcatheter Electrosurgery
  • Reagent Development for Small Cell Number ChIC-seq

A Question & Answer Amendment has been published with the purpose of responding to questions submitted by interested parties to gain better understanding of the 2017 NIH/CDC SBIR Contract Solicitation:  Q&A Amendment 2

If you missed the August 15, 2017 webinar on PHS 2018-1 solicitation, check it out: Webinar Slides

For more information on how to apply, please read the full Notice:  NOT-OD-17-089


Nov 7 - 9 Meet with NHLBI at the HHS SBIR/STTR Conference

19th Annual HHS SBIR/STTR Conference

November 7 - 9, Milwaukee, Wisconsin

Register HERE

This conference is relevant to a diverse audience, including biomedical entrepreneurs; principal investigators; grants and contracts administrators; and industry partners and investors.

Top 3 Reasons to Attend:

1.  Meet one-on-one with HHS SBIR/STTR program managers

Over 100 federal staff, including representatives from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Small Business Administration (SBA), Administration for Community Living (ACL), and HHS Office of the Inspector General (OIG) will be holding one-on-one meetings and giving presentations. You will have the chance to get one-on-one feedback about your technology proposal!

2.  Hear from successful HHS SBIR/STTR awardees 

Gain first-hand knowledge from experienced and successful applicants, potential funding partners and companies during interactive workshops and sessions. These sessions include a diverse group of successful awardees, including women-owned small businesses and socially and economically disadvantaged small businesses.

3.  Learn how to develop a competitive application

Many sessions focus on how to develop and submit your SBIR/STTR application. Topics include:

  • How to submit your SBIR/STTR grant proposal electronically via ASSIST
  • FDA regulatory requirements for drugs and devices
  • Important considerations to protect your intellectual property
  • Top 10 Dos and Don’ts for SBIR/STTR proposal development
  • Understanding indirect costs and financial accounting systems
  • What you need to know about human subjects and animal research
  • The differences between SBIR grants and contracts

4.  NHLBI SBIR/STTR experts from Office of Translational Alliances and Coordination will present

OTAC’s Chris Sasiela:

  • FDA Regulatory Basics for Small Businesses” on Tuesday afternoon and Wednesday morning. 

OTAC’s Gary Robinson: 

  • NIH Resources for Small Businesses” on Tuesday afternoon.
  • Writing Your Phase II Commercialization Plan” on Wednesday and Thursday afternoon.

For more information, please visit Clinical & Translational Science Institute


Dec 8 deadline - USPTO's Patents for Humanity Competition

Application due date: December 8, 2017  

The United States Patent & Trademark Office recently announced their Patents for Humanity competition, which recognizes innovators who use game-changing technology to meet global humanitarian challenges. Winners are publicly recognized and receive an acceleration certificate to expedite select USPTO proceedings.

Visit the USPTO's Patents for Humanity website for more information and how to apply

Download the application HERE


FDA Publishes New Medical Device Guidance Documents

Are you as jazzed as we are to know that FDA is willing to share the way they think about product development with you? Are you wondering if there is a guidance document you should know about? You can easily search the FDA Guidance database to find out if the FDA has a formal opinion on any aspect of your technology development.  

On Tuesday, FDA released three new guidance documents that may be of interest to our medical device community:


Meet NHLBI Small Business Experts

10/31 -  2017 NIH Innovation Conference - New York, NY

11/1 - 11/2 - Life Sciences Summit - New York, NY

11/7 - 11/9 -  19th Annual HHS SBIR/STTR Conference - Milwaukee, WI

11/13 – 11/15NSF Workshop on Organizational Issues in Technology Transfer at Federal Laboratories – Phoenix, AZ

11/14Partnering for Cures – San Francisco, CA

01/08 – 01/10Biotech Showcase – San Francisco, CA

01/09Redefining Early Stage Investments (RESI) - San Francisco, CA

01/1013th Annual Non-Dilutive Funding Summit - San Francisco, CA

02/1802/21 - AUTM 2018 – Phoenix, AZ

03/0303/06CRT 2018 – Washington, DC